small-molecule drug discovery and development

Arisan Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of novel oral therapeutics for emerging infectious diseases and metabolic disorders. It is advancing government-funded small-molecule programs for Ebola virus disease and Lassa fever, and exploring applications of a clinical-stage small-molecule platform in cardiometabolic disorders including hypertriglyceridemia, visceral adiposity, MASLD/MASH, and obesity-related conditions.

Read more

clinical-stage therapeutic development